IBRUTINIB IN MONOTHERAPY AS A TREATMENT OF RELAPSED MANTLE CELL LYMPHOMA IN THE CENTRAL NERVOUS SYSTEM. CASE REPORT

被引:0
|
作者
Morales de la Plaza, A. [1 ]
Santero Garcia, M. [1 ]
Sebrango Sadia, A. [1 ]
机构
[1] Hosp Univ Torrejon, Madrid, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PB-060
引用
收藏
页码:337 / 337
页数:1
相关论文
共 50 条
  • [41] RITUXIMAB MONOTHERAPY FOR TREATMENT OF RARE LOW GRADE PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; A CASE REPORT AND LITERATURE REVIEW
    Tobin, Grace
    Neil, Elizabeth
    NEURO-ONCOLOGY, 2021, 23 : 110 - 110
  • [42] Histiocytic Sarcoma of the Central Nervous System. Case Report
    Gryniewicz-Kwiatkowska, Olga
    Rutynowska, Olga
    Grajkowska, Wieslawa
    Nowak, Katarzyna
    Dembowska-Baginska, Bozenna
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S63 - S63
  • [43] ECONOMIC EVALUATION OF IBRUTINIB FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE-CELL LYMPHOMA IN MEXICO
    Carlos, F.
    Herrera, M.
    Salazar, A.
    Aguirre, A.
    Gonzalez-Michaca, L.
    VALUE IN HEALTH, 2016, 19 (03) : A249 - A249
  • [44] Ibrutinib and rituximab association: interest of a chemotherapy free treatment in relapsed or refractory mantle cell lymphoma
    Philippe, Laure
    HEMATOLOGIE, 2016, 22 (01): : 12 - 13
  • [45] Preclinical Evaluation of Ibrutinib for Central Nervous System Lymphoma
    Pouzoulet, Frederic
    Rezai, Keyvan
    Li, Zhimin
    Qiu Yushi
    Tun, Han W.
    Labiod, Dalila
    Bonnet-Boissinot, Sarah
    Soussain, Carole
    BLOOD, 2016, 128 (22)
  • [46] Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma
    Raizer, Jeffrey J.
    Rademaker, Alfred
    Evens, Andrew M.
    Rice, Laurie
    Schwartz, Margaret
    Chandler, James P.
    Getch, Christopher C.
    Tellez, Claudia
    Grimm, Sean A.
    CANCER, 2012, 118 (15) : 3743 - 3748
  • [47] Lenalidomide in the treatment of relapsed primary central nervous system lymphoma (PCNSL).
    Houillier, Caroline
    Choquet, Sylvain
    Touitou, Valerie
    Martin-Duverneuil, Nadine
    Khe Hoang-Xuan
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] LENALIDOMIDE IN THE TREATMENT OF RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
    Houillier, C.
    Choquet, S.
    Touitou, V.
    Martin-Duverneuil, N.
    Hoang-Xuan, K.
    NEURO-ONCOLOGY, 2014, 16
  • [49] Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single-centre analysis
    Lauer, Eliza M.
    Waterhouse, Miguel
    Braig, Moritz
    Mutter, Jurik
    Bleul, Sabine
    Duque-Afonso, Jesus
    Duyster, Justus
    Marks, Reinhard
    Reinacher, Peter C.
    Prinz, Marco
    Illerhaus, Gerald
    Finke, Juergen
    Schorb, Elisabeth
    Scherer, Florian
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (02) : E110 - E114
  • [50] Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to monotherapy with topotecan.
    Fischer, L
    Korfel, A
    Thiel, E
    BLOOD, 2002, 100 (11) : 297B - 297B